Patents by Inventor Shahram Aghaibeik-Lavasani

Shahram Aghaibeik-Lavasani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for treatment and prophylaxis of intestinal infection and inflammation
    Patent number: 10632159
    Abstract: The present invention relates to a composition for use in the treatment and/or prevention of a gastrointestinal condition, comprising at least one Lactobacillus strain, wherein the Lactobacillus strain is chosen from the group consisting of one L. salivarius strain, three L. plantarum strains and one L. brevis strain, wherein the L. salivarius strain is L. salivarius CW30 (LMG P-28887), wherein the L. plantarum strains are L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P-28884), and L. plantarum KS1 1 (LMG P-28885), and wherein the L. brevis strain is L. brevis SH1 1 1 (LMG P-28888). The present invention also relates to an enema comprising a composition according to the present invention. The present invention also relates to an isolated strain chosen from the group L. salivarius CW30 (LMG P-28887), L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P-28884), L. plantarum KS11 (LMG P-28885) and L. brevis SH111 (LMG P-28888).
    Type: Grant
    Filed: August 23, 2016
    Date of Patent: April 28, 2020
    Assignee: IMMUNEBIOTECH MEDICAL SWEDEN AB
    Inventors: Shahram Aghaibeik-Lavasani, Mehrnaz Nouri
  • COMPOSITION AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INTESTINAL INFECTION AND INFLAMMATION
    Publication number: 20180243353
    Abstract: The present invention relates to a composition for use in the treatment and/or prevention of a gastrointestinal condition, comprising at least one Lactobacillus strain, wherein the Lactobacillus strain is chosen from the group consisting of one L. salivarius strain, three L. plantarum strains and one L. brevis strain, wherein the L. salivarius strain is L. salivarius CW30 (LMG P-28887), wherein the L. plantarum strains are L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P-28884), and L. plantarum KS1 1 (LMG P-28885), and wherein the L. brevis strain is L. brevis SH1 1 1 (LMG P-28888). The present invention also relates to an enema comprising a composition according to the present invention. The present invention also relates to an isolated strain chosen from the group L. salivarius CW30 (LMG P-28887), L. plantarum Y1An734 (LMG P-28886), L. plantarum SH1313 (LMG P-28884), L. plantarum KS11 (LMG P-28885) and L. brevis SH111 (LMG P-28888).
    Type: Application
    Filed: August 23, 2016
    Publication date: August 30, 2018
    Inventors: Shahram AGHAIBEIK-LAVASANI, Mehrnaz NOURI
  • Use of for treatment of autoimmune diseases
    Patent number: 8936783
    Abstract: The present technology relates to the use of at least one strain of probiotic bacteria selected from Lactobacillus for the manufacture of a medicament for the treatment and/or prevention of an autoimmune disease.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: January 20, 2015
    Assignee: Probi AB
    Inventors: Jan Alenfall, Anna Berggren, Carola Rask, Agnes Wold, Shahram Aghaibeik-Lavasani
  • Use of Lactobacillus for Treatment of Autoimmune Diseases
    Publication number: 20090208469
    Abstract: The present technology relates to the use of at least one strain of probiotic bacteria selected from Lactobacillus for the manufacture of a medicament for the treatment and/or prevention of an autoimmune disease.
    Type: Application
    Filed: October 6, 2006
    Publication date: August 20, 2009
    Applicant: PROBI AB
    Inventors: Jan Alenfall, Anna Berggren, Carola Rask, Agnes Wold, Shahram Aghaibeik-Lavasani